Medical expert of the article

Endocrinologist

New publications

Pancreatic tumors with carcinoid syndrome

Alexey Kryvenko, medical expert
Last reviewed: 07.07.2025

All iLive content is medically reviewed or fact checked to ensure as much factual accuracy as possible.

We have strict sourcing guidelines and only link to reputable media sites, academic research institutions and, whenever possible, medically peer reviewed studies. Note that the numbers in parentheses ([1], [2], etc.) are clickable links to these studies.

If you feel that any of our content is inaccurate, out-of-date, or otherwise questionable, please select it and press Ctrl + Enter.

Symptoms
Where does it hurt?
Diagnostics

What do need to examine?
How to examine?
Treatment
Who to contact?

In most cases, they are found in the intestines in the ileocecal angle and in the bronchi, but are rarely functional.

Pancreatic carcinoid is capable of secreting almost all peptides characteristic of ortho- and paraendocrine neoplasms.

trusted-source [ 1 ], [ 2 ], [ 3 ], [ 4 ]

Symptoms pancreatic tumors with carcinoid syndrome.

Carcinoid syndrome is caused by the secretion of biogenic amines and is clinically manifested by hot flashes, tachycardia, diarrhea and attacks of bronchial asthma. The presence of clinical manifestations indicates that biogenic amines have overcome the liver barrier as a result of the metastatic process.

Where does it hurt?

Pancreatic pain

Left side pain

Diagnostics pancreatic tumors with carcinoid syndrome.

Laboratory diagnostics reveal high levels of serotonin, histamine and 5-hydroxytryptophan in the blood of patients, as well as increased excretion of 5-hydroxyindoleacetic acid in the urine.

trusted-source [ 5 ], [ 6 ], [ 7 ]

What do need to examine?

Pancreas

The endocrine part of the pancreas

How to examine?

Pancreatic ultrasound

X-ray of the pancreas

Diagnosis of the pancreas

Who to contact?

Oncologist

Treatment pancreatic tumors with carcinoid syndrome.

Drug treatment of carcinoid syndrome involves the combined use of histamine H1- and H2-receptor antagonists or methyldopa. There are observations of a positive effect from the use of somatostatin.